The prevalence of acute septic arthritis in Western Europe is ≈4--10 cases/100,000 inhabitants ([@R1]). We report a case of posttraumatic knee septic arthritis in an immunocompetent patient in France that was caused by *Erwinia billingiae*, a gram-negative environmental bacterium of the family *Enterobacteriaceae*. We also review the characteristics of *Erwinia* species and infections.

On April 9, 2017, a 65-year-old man with an unremarkable medical history was admitted to an emergency unit in Nice, southern France, for painful right knee swelling that occurred a few hours after a Phoenix palm tree needle pierced the area. The foreign body was partly removed, and the wound was sutured. The patient was discharged without any knee pain and given a prescription for amoxicillin/clavulanic acid (1 g 3×/d for 6 d).

On April 22, the patient was admitted to the emergency unit of our hospital in Paris because of sudden right knee pain and fever. Synovial fluid collected by knee puncture the day of his admission to the orthopedic unit (April 23) contained 118 × 10^9^ leukocytes/L, consisting of 64% polymorphonuclear cells, 33% lymphocytes, and 3% other leukocytes; no microorganism could be identified after Gram staining and cultures. A second knee puncture was performed 3 days after admission, and gram-negative rods grew within 2 days solely within the anaerobic blood culture vial (BacT/ALERT SN; bioMérieux, <https://www.biomerieux.com>). Subcultures of the blood culture vial were positive after 24 hours of incubation at 37°C on blood agar (Trypticase Soy agar + 5% horse blood and Mueller Hinton 2 agar + 5% sheep blood; bioMérieux) and Drigalski agar (BD, <https://www.bd.com>) under aerobic conditions and chocolate agar (BD) under microaerobic conditions.

Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (Bruker Daltonik, <https://www.bruker.com>) was performed on colonies and failed to correctly identify the species. Therefore, we performed species identification by 16S rRNA amplification and sequencing with primers RNA-S (16S, 5′-AGAGTTTGATCCTGGYTCAG-3′) and RNA-AS (16AS, 5′-CTTTACGCCCARTAAWTCCG-3′) at a hybridization temperature of 52°C. We amplified a 521-bp sequence that matched the *E. billingiae* genome of 2 isolates with 99.4% similarity (GenBank accession nos. JQ929658 and JN175337). Other closely related species displayed lower similarities: *Pantoea rwandensis* (99.0%), *Erwinia persicina* (98.9%), *Pantoea coffeiphila* (98.7%), *Erwinia tasmaniensis* (98.5%), and *Erwinia aphidicola* (98.3%). Following guidelines of the Antibiogram Committee of the French Society for Microbiology (<https://www.sfm-microbiologie.org/2019/01/07/casfm-eucast-2019>), we tested the *E*. *billingiae* isolate with the antimicrobial drugs recommended for *Enterobacteriaceae*; the isolate was susceptible to all these drugs, including ampicillin.

Because of the lack of clinical improvement, the joint was washed on day 6 after admission. After this intervention, an empiric antimicrobial drug treatment was started with amoxicillin/clavulanic acid (2 g 3×/d intravenously). Once results of drug susceptibility testing became available (i.e., 10 days after admission), his treatment was switched to cefotaxime (2 g 3×/d intravenously) and ciprofloxacin (500 mg 2×/d orally for 8 d), followed by ciprofloxacin (500 mg 2×/d alone for 38 additional days). Total duration of treatment was 45 days. The clinical evolution of this patient was favorable; he fully recovered and had no relapses up to 1 year after treatment completion.

In the past, some members of the *Erwinia* genus were reassigned to the genera *Enterobacter* or *Pantoea*. *Erwinia* spp. are ubiquitous in the environment, especially in water ecosystems and soils. Plant-associated *Erwinia* species comprise epiphytic nonpathogenic (i.e., *E. billingiae* and *E. tasmaniensis*) and pathogenic (i.e., *E. amylovora* and *E. pyrifoliae*) species. The MALDI-TOF mass spectrometry system failed to identify the bacterium, even though *E. billingiae* is contained in the database for either method used (direct deposit or on-plate formic acid treatment). Future expansion of the database with more spectra will likely improve the performance of the MALDI-TOF mass spectrometry system for *E. billingiae* identification. Indeed, the database contains fewer spectra of *E. billingiae* (n = 4) than those of frequently encountered species in medical microbiological laboratories, such as *Escherichia coli* (n = 14) and *Staphylococcus aureus* (n = 10).

To further investigate *Erwinia* infections in humans, we reviewed reports available in PubMed published during 1967--2017 written in English by using the keywords "*Erwinia*" and "infection" ([Table](#T1){ref-type="table"}). Among the 17 cases reported, the sites of infection were diverse, and most (53%, 9/17) cases occurred after a direct inoculation during an injury with a plant ([Table](#T1){ref-type="table"}). We found no reports of osteoarticular infections with *Erwinia*; the only other *E. billingiae* case reported was a dermohypodermitis ([Table](#T1){ref-type="table"}). In that case, as in the case we report here, an injury with a plant was reported.

###### Case reports from the literature of infection caused by *Erwinia* spp.\*

  Patient age, y/sex   Type of infection                     Inoculated   Published (actual) species name                    Identification method†   Antimicrobial drug; treatment duration                                                    Surgery   Clinical evolution   Ref
  -------------------- ------------------------------------- ------------ -------------------------------------------------- ------------------------ ----------------------------------------------------------------------------------------- --------- -------------------- --------
  65/F                 SSTI                                  Yes          *Erwinia* sp.                                      Biochemical              Penicillin, then penicillin and sulfisoxazole; NA                                         Yes       Recovered            (*2*)
  Adult/F              Peritoneal dialysis fluid infection   No           *Erwinia* strains of the lathyri-herbicola group   Biochemical              NA; NA                                                                                    No        NA                   (*3*)
  Adult/F              SSTI                                  Yes          *Erwinia* strains of the lathyri-herbicola group   Biochemical              Chloramphenicol; NA                                                                       No        Recovered            (*3*)
  Adult/M              SSTI                                  Yes          *Erwinia* strains of the lathyri-herbicola group   Biochemical              Ampicillin; NA                                                                            No        Recovered            (*3*)
  Adult/M              SSTI                                  Yes          *Erwinia* strains of the lathyri-herbicola group   Biochemical              Penicillin; NA                                                                            No        Recovered            (*3*)
  Adult/M              Brain abscess                         No           *Erwinia* strains of the lathyri-herbicola group   Biochemical              NA; NA                                                                                    Yes       NA                   (*3*)
  17/F                 Bacteremia                            Yes          *Erwinia herbicola*; (*Pantoea agglomerans*)       Biochemical              Streptomycin and penicillin; NA                                                           No        Recovered            (*4*)
  17/M                 Bacteremia                            Yes          *E. herbicola*(*P. agglomerans*)                   Biochemical              Cephalothin; NA                                                                           No        Recovered            (*4*)
  28/M                 Bacteremia                            Yes          *Erwinia* sp.                                      Biochemical              Ampicillin then ampicillin and kanamycin; NA                                              No        Recovered            (*4*)
  57/M                 Brain abscess                         No           *Erwinia* sp.                                      Biochemical              Penicillin and streptomycin, then ampicillin, then chloramphenicol, then gentamicin; NA   Yes       Recovered            (*5*)
  70/M                 Endophtalmitis                        Yes          *E. herbicola*(*P. gglomerans*)                    Biochemical              Cefazolin and gentamicin; 37 d until surgery (NA after surgery)                           Yes       Recovered            (*6*)
  66/F                 UTI                                   No           *E. herbicola*(*P. agglomerans*)                   Biochemical              NA; NA                                                                                    No        Died                 (*7*)
  69/F                 UTI                                   No           *E. herbicola*(*P. agglomerans*)                   Biochemical              NA; NA                                                                                    No        Recovered            (*7*)
  62/F                 UTI                                   No           *E. herbicola*(*P. agglomerans*)                   Biochemical              NA; NA                                                                                    No        Recovered            (*7*)
  46/M                 Endocarditis                          No           *E. herbicola*(*P. agglomerans*)                   Biochemical              Cefotaxime and netilmicin; 6 weeks                                                        No        Recovered            (*8*)
  79/F                 Cervical lymphadenitis                No           *Erwinia tasmaniensis*(*E. tasmaniensis*           16S rRNA‡                Ciprofloxacin; 2 weeks                                                                    Yes       Recovered            (*9*)
  40/M                 Dermohypodermitis                     Yes          *Erwinia billingiae*(*E. billingiae*)              NA                       Ciprofloxacin; 14 d                                                                       No        Recovered            (*10*)

\*NA, not available; ref, reference; SSTI, skin and soft tissue infection; UTI, urinary tract infection. †Biochemical testing included Kligler iron agar (assess slant, butt, H~2~S production), tests for carbohydrate fermentation (adonitol, fructose, galactose, glucose, inositol, lactose, maltose, mannitol, mannose, raffinose, rhamnose, salicin, sorbitol, sucrose, xylose), ONPG (ortho-nitrophenyl-galactosidez) test, gluconate test, gelatin hydrolysis test, tests for nitrate reduction and N~2~ production, indole test, methyl red test, Voges--Proskauer test, casein hydrolysis test, citrate utilization test, urease test, catalase test, oxidase test, arginine dihydrolase test, lysine decarboxylase test, ornithine decarboxylase test, lipase test, amylase test, pectinase test, deoxyribonuclease test, lecithinase test, salinity tests (2.5% NaCl, 10.0% NaCl \[pH 5.6\]), Tetrazolium-Formazan test (TTC \[triphenyl tetrazolium chloride\]), cetrimide selection agar, tyrosinase test, and tests for carbohydrate assimilation (glucose, acetate, lactate, succinate). ‡*E. tasmaniensis* (98.9%), *E. toletana* (98.8%), and *E. billingiae* (98.1%) (EzTaxon Database, <https://everipedia.org/wiki/lang_en/EzTaxon_Database>).

This case report illustrates the importance of the methods used for bacterial identification to correctly diagnose such infections. Biochemical methods ([@R2]--[@R8]) and MALDI-TOF mass spectrometry (as done in our investigation) could result in misidentification. This report highlights the usefulness of analyzing MALDI-TOF mass spectrometry scores before assigning a species identity and sequencing the 16S RNA gene for bacteria not identifiable by conventional methods.

*Suggested citation for this article*: Bonnet I, Bozzi B, Fourniols E, Mitrovic S, Soulier-Escrihuela O, Brossier F, et al. *Erwinia billingiae* as unusual cause of septic arthritis, France, 2017. Emerg Infect Dis. 2019 Aug \[*date cited*\]. <https://doi.org/10.3201/eid2508.181073>

Deceased.

Group members are listed at the end of this article.

Dr. Bonnet is a clinical microbiologist in the Bacteriology Laboratory, Pitié Salpêtrière--Charles Foix University Hospital, in Paris, France. She is also part of research team 2 (Bacteriology), Centre d'Immunologie et des Maladies Infectieuses, Cimi-Paris, INSERM, U1135, Sorbonne Université, Paris, France. Her research interests relate to microbiology, especially antimicrobial drug resistance, mycobacteria, and infectious disease.

[^1]: Members of the Pitié-Salpêtrière Infection Ostéo-articulaire Group: Barut Nicolas, Calin Ruxandra, Clarençon Frédéric, Daas Georges, Fautrel Bruno, Fustier Anne, Gandjbakhch Frédérique, Haddad Elie, Khiami Frédéric, Lazennec Jean-Yves, Marchand Maxime, Mercy Guillaume, Metz Carole, Miu Mihaela, Monsel Gentiane, Monzani Quentin, Reubrecht Vanessa, and Zahr Noël.
